10100SJ0043 EngrossedLRB101 11737 MST 58399 r


  
1
SENATE JOINT RESOLUTION NO. 43
2
(As Amended by Senate Amendment No. 1)

  
 
3    WHEREAS, The human papillomavirus (HPV) is the most common 
4sexually transmitted virus in the United
States; nearly 14 
5million people become infected each year; and
 
6    WHEREAS, HPV causes approximately 33,700 cases of 
7HPV-associated cancers each year, including
cervical, anal, 
8and oropharyngeal cancers; and
 
9    WHEREAS, 9-valent HPV vaccine protects against nine types 
10of HPV infection; and
 
11    WHEREAS, The HPV vaccine was tested before being licensed 
12by the Food and Drug
Administration and continues to be 
13monitored by the Centers for Disease Control and
Prevention and 
14the Food and Drug Administration; and
 
15    WHEREAS, The most common side effects are mild and include 
16pain, redness, or swelling in the arm where the shot is given; 
17dizziness, fainting, nausea, and headaches can also occur; and
 
18    WHEREAS, The American Academy of Pediatrics (AAP) and the 
19Advisory Committee on Immunization
Practices (ACIP) recommend 
20two doses of HPV vaccine for males and females ages 11-12; the

 
 
10100SJ0043 Engrossed- 2 -LRB101 11737 MST 58399 r

1vaccine is approved for men and women through age 45; and
 
2    WHEREAS, In Illinois, only 50 percent of males and females 
3ages 13-17 years were up to date on HPV vaccination in
2017; 
4therefore, be it
 
5    RESOLVED, BY THE SENATE OF THE ONE HUNDRED FIRST GENERAL

6ASSEMBLY OF THE STATE OF ILLINOIS, THE HOUSE OF REPRESENTATIVES

7CONCURRING HEREIN,
that we encourage adolescents in Illinois to

8receive the HPV vaccine to protect themselves against HPV

9infection and HPV-related cancers.